News of Note—Convictions overturned; Hi-Tech expands

Financial market data. Image: Pixabay

> A federal judge has overturned the convictions of a co-owner and a former employee of the New England Compounding Center, the outsourcing pharmacy from which tainted drugs in 2012 caused a fungal meningitis outbreak that led to more than 100 deaths. The incident led to a law giving federal regulators oversight of some outsourcing facilities. Story  

> API and OTC drugmaker Hi-Tech Pharmaceuticals in Norcross, Georgia, has expanded with a 13,000-square-foot facility that includes formulation development, quality control laboratories and a pilot scale manufacturing operation. Release

> India's Lupin was awarded the India Packaging Award 2019 for a patient awareness initiative and its special packaging for a cardiology drug. Release


Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This on-demand webinar discusses the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.